KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Fulgent Genetics (FLGT) Invested Capital (2016 - 2025)

Historic Invested Capital for Fulgent Genetics (FLGT) over the last 11 years, with Q3 2025 value amounting to $1.2 billion.

  • Fulgent Genetics' Invested Capital fell 63.8% to $1.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 billion, marking a year-over-year decrease of 63.8%. This contributed to the annual value of $1.2 billion for FY2024, which is 17.58% up from last year.
  • According to the latest figures from Q3 2025, Fulgent Genetics' Invested Capital is $1.2 billion, which was down 63.8% from $1.1 billion recorded in Q2 2025.
  • In the past 5 years, Fulgent Genetics' Invested Capital registered a high of $1.3 billion during Q2 2022, and its lowest value of $818.6 million during Q1 2021.
  • In the last 5 years, Fulgent Genetics' Invested Capital had a median value of $1.2 billion in 2024 and averaged $1.2 billion.
  • Its Invested Capital has fluctuated over the past 5 years, first skyrocketed by 100985.6% in 2021, then plummeted by 1012.77% in 2024.
  • Fulgent Genetics' Invested Capital (Quarter) stood at $1.2 billion in 2021, then increased by 8.37% to $1.3 billion in 2022, then decreased by 9.81% to $1.2 billion in 2023, then increased by 0.18% to $1.2 billion in 2024, then dropped by 0.55% to $1.2 billion in 2025.
  • Its Invested Capital stands at $1.2 billion for Q3 2025, versus $1.1 billion for Q2 2025 and $1.2 billion for Q1 2025.